ARCHIVES

FDA Authority To Remove Paclitaxel Patent Questioned.

This article is from The Cancer Letter archive.

Vol. 27 No. 06 | February 9, 2001

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: RFA Available: Teams For Molecular Target Assessment

November 26, 1999

Clearinghouse Opens With Predictable Controversy; Brown Urges ‘Open Minds’

November 12, 1976

Bush Budget Reinforces Funding Trends, Reports Say.

July 13, 2001

Cancer Programs Close Amid Gridlock

October 4, 2013

Arimidex Reduces Relapse Compared To Tamoxifen, Large Study Reports

December 28, 2001

An Impromptu Group Proposes Standards For Publication Of Genomics Research

October 1, 2010